LORAINE IUNE SANTIAGO: Open Payments
NPI 1346843281 · SPRING VALLEY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$909 in 46 payments from 10 companies in 2025. Trend: 2023 $1,714 · 2024 $565 · 2025 $909
Food & beverage: $909
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 27 | $316 |
| Amgen Inc. | 6 | $231 |
| Novartis Pharmaceuticals Corporation | 4 | $162 |
| E.R. Squibb & Sons, L.L.C. | 3 | $66 |
| Edwards Lifesciences Corporation | 1 | $28 |
| Novo Nordisk Inc | 1 | $27 |
| Alnylam Pharmaceuticals Inc. | 1 | $26 |
| Lilly USA, LLC | 1 | $22 |
| BridgeBio Pharma, Inc. | 1 | $18 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
Products named: VYNDAQEL, REPATHA, CAMZYOS, ELIQUIS, LEQVIO, SAPIEN 3 Ultra RESILIA, Wegovy, AMVUTTRA.
Industry payments across CA — which companies pay providers there.
